The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Leucadia National's revenues will increase 1023.9% and EPS will decrease -204.2%.
The average estimate for revenue is $2.65 billion. On the bottom line, the average EPS estimate is $1.24.
Last quarter, Leucadia National notched revenue of $2.14 billion. GAAP reported sales were much higher than the prior-year quarter's $753.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at -$0.81. GAAP EPS were -$0.81 for Q2 versus $0.75 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 9.9%, 7,630 basis points worse than the prior-year quarter. Operating margin was 4.3%, 6,840 basis points worse than the prior-year quarter. Net margin was -9.2%, 3,390 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $9.41 billion. The average EPS estimate is $3.05.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,292 members out of 1,318 rating the stock outperform, and 26 members rating it underperform. Among 368 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 364 give Leucadia National a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Leucadia National is hold, with an average price target of $24.00.
- Add Leucadia National to My Watchlist.